Adrenergic regulation of immunity

Psychoneuroimmunology, Two-Volume Set

Volumn 1, Issue , 2007, Pages 63-83

  Sanders, Virginia M ^a   Kavelaars, Annemieke ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882541473     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088576-3/50006-X     Document Type: Chapter

References (220)

1. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
2. Ackerman K.D., Madden K.S., Livnat S., Felten S.Y., Felten D.L. Neonatal sympathetic denervation alters the development of in vitro spleen cell proliferation and differentiation. Brain Behav. Immunity 1991, 5:235-261.
3. Ader R., Cohen N. Behaviorally conditioned immunosuppression. Psychosom. Med. 1975, 37:333-340.
4. Agarwal S.K., Marshall G.D.Jr. Glucocorticoidinduced type 1/type 2 cytokine alterations in humans: a model for stress-related immune dysfunction. J. Interferon Cytokine Res. 1998, 18:1059-1068.
5. Agarwal S.K., Marshall G.D.Jr. In vivo alteration in type-1 and type-2 cytokine balance: a possible mechanism for elevated total IgE in HIV-infected patients. Hum. Immunol. 1998, 59:99-105.
6. Agarwal S.K., Marshall G.D. Beta-adrenergic modulation of human type-1/type-2 cytokine balance. J. Allergy Clin. Immunol. 2000, 105:91-98.
7. Alaniz R.C., Thomas S.A., Perez-Melgosa M., Mueller K., Farr A.G., Palmiter R.D., Wilson C.B. Dopamine betahydroxylase deficiency impairs cellular immunity. Proc. Natl. Acad. Sci. USA, 1999, 96:2274-2278.
8. Baker G.H. Life events before the onset of rheumatoid arthritis. Psychother. Psychosom. 1982, 38:173-177.
9. Bellinger D.L., Ackerman K.D., Felten S.Y., Felten D.L. A longitudinal study of age-related loss of noradrenergic nerves and lymphoid cells in the rat spleen. Exp. Neurol 1992, 116:295-311.
10. Ben Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav. Immun. 2003, 17:S27-S36. Suppl 1.
11. Benovic J.L., Strasser R.H., Caron M.G., Lefkowitz R.J. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. PNAS 1986, 83:2797-2801.
12. Benschop R.J., Jacobs R., Sommer B., Schurmeyer T.H., Raab J.R., Schmidt R.E., Schedlowski M. Modulation of the immunologic response to acute stress in humans by betablockade or benzodiazepines. FASEB J. 1996, 10:517-524.
13. Benschop R.J., Nieuwenhuis E.E., Tromp E.A., Godaert G.L., Ballieux R.E., van Doornen L.J. Effects of betaadrenergic blockade on immunologic and cardiovascular changes induced by mental stress. Circulation 1994, 89:762-769.
14. Benschop R.J., Oostveen F.G., Heijnen C.J., Ballieux R.E. Beta 2-adrenergic stimulation causes detachment of natural killer cells from cultured endothelium. Eur. J. Immunol. 1993, 23:3242-3247.
15. Benschop R.J., Rodriguez-Feuerhahn M., Schedlowski M. Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav. Immun. 1996, 10:77-91.
16. Bergquist J., Tarkowski A., Ewing A., Ekman R. Catecholaminergic suppression of immunocompetent cells. Immunol. Today 1998, 19:562-567.
17. Besedovsky H., Del Rey A., Sorkin E., Da Prada M., Burri R., Honegger C. The immune response evokes changes in brain noradrenergic neurons. Science 1983, 221:564-566.
18. Besedovsky H., Sorkin E., Felix D., Haas H. Hypothalamic changes during the immune process. Eur. J. Immunol. 1977, 7:323-325.
19. Besedovsky H.O., Del Rey A. Immune-neuro-endocrine interactions: facts and hypotheses. Endocr. Rev. 1996, 17:64-102.
20. Besedovsky H.O., Del Rey A., Sorkin E., Da Prada M., Keller H.H. Immunoregulation mediated by the sympathetic nervous system. Cell. Immunol. 1979, 48:346-355.
21. Betz M., Fox B.S. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 1991, 146:108-113.
22. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proc.Natl.Acad.Sci.USA 2003, 100:1920-1925.
23. Biondi M., Zannino L.-G. Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animals and man: a review. Psychother. Psychosom. 1997, 66:3-26.
24. Bloemen P.G., van den Tweel M.C., Henricks P.A., Engels F., Kester M.H., van de Loo P.G., Blomjous F.J., Nijkamp F.P. Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am. J. Physiol. 1997, 272:L580-L587.
25. Blomhoff H.K., Smeland E.B., Beiske K., Blomhoff R., Ruud E., Bjoro T., Pfeifer-Ohlsson S., Watt R., Funderud S., Godal T., Ohlsson R. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes. J. Cell. Physiol. 1987, 131:426-433.
26. Borger P., Hoekstra Y., Esselink M.T., Postma D.S., Zaagsma J., Vellenga E., Kauffman H.F. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype. Am. J. Respir. Cell Mol. Biol. 1998, 19:400-407.
27. Borger P., Kauffman H.F., Postma D.S., Vellenga E. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 1996, 87:691-698.
28. Borger P., Kauffman H.F., Postma D.S., Vellenga E. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway. Blood 1996, 87:691-698.
29. Cao L., Filipov N.M., Lawrence D.A. Sympathetic nervous system plays a major role in acute cold/restraint stress inhibition of host resistance to Listeria monocytogenes. J. Neuroimmunol. 2002, 125:94-102.
30. Caruso C., Lio D., Cavallone L., Franceschi C. Aging, longevity, inflammation, and cancer. Ann. N. Y. Acad. Sci. 2004, 1028:1-13.
31. Cazaux C.A., Sterin-Borda L., Gorelik G., Cremaschi G.A. Down-regulation of beta-adrenergic receptors induced by mitogen activation of intracellular signaling events in lymphocytes. FEBS Lett. 1995, 364:120-124.
32. Chao H.J., Hsu Y.C., Yuan H.P., Jiang H.S., Hsueh C.M. The conditioned enhancement of neutrophil activity is catecholamine dependent. J. Neuroimmunol. 2005, 158:159-169.
33. Chelmicka-Schorr E., Checinski M., Arnason B.G.W. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis. J. Neuroimmunol. 1988, 17:347-350.
34. Chen D., Rothenberg E.V. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 1994, 179:931-942.
35. Cobelens P.M., Kavelaars A., Vroon A., Ringeling M., van der Zee R., van Eden W., Heijnen C.J. The beta 2-adrenergic agonist salbutamol potentiates oral induction of tolerance, suppressing adjuvant arthritis and antigen-specific immunity. J. Immunol. 2002, 169:5028-5035.
36. Cohen D.P., Rothstein T.L. Adenosine 3□CE 5□CE-cyclic monophosphate modulates the mitogenic responses of murine B lymphocytes. Cell. Immunol. 1989, 121:113-124.
37. Cole S.W., Korin Y.D., Fahey J.L., Zack J.A. Norepinephrine accelerates HIV replication via protein kinase Adependent effects on cytokine production. J. Immunol. 1998, 161:610-616.
38. Cook-Mills J.M., Mokyr M.B., Cohen R.L., Perlman R.L., Chambers D.A. Neurotransmitter suppression of the in vitro generation of a cytotoxic T lymphocyte response against the syngeneic MOPC-315 plasmacytoma. Cancer Immunol. Immunother. 1995, 40:79-87.
39. Corcoran L.M., Karvelas M. Oct-2 is required in T cell-independent B cell activation for G1 progression and for proliferation. Immunity 1994, 1:635-645.
40. Crocker I.C., Townley R.G., Khan M.M. Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and-5 secretion by human T-helper type 2 cells. Immunopharmacol. 1996, 31:223-235.
41. Cross R.J., Jackson J.C., Brooks W.H., Sparks D.L., Markesbery W.R., Roszman T.L. Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment. Immunology 1986, 57:145-152.
42. de Coupade C., Gear R.W., Dazin P.F., Sroussi H.Y., Green P.G., Levine J.D. Beta 2-adrenergic receptor regulation of human neutrophil function is sexually dimorphic. Br. J. Pharmacol. 2004, 143:1033-1041.
43. Del Rey A., Besedovsky H.O., Sorkin E., Da Prada M., Arrenbrecht S. Immunoregulation mediated by the sympathetic nervous system II. Cell. Immunol. 1981, 63:329-334.
44. Del Rey A., Kabiersch A., Petzoldt S., Besedovsky H.O. Sympathetic abnormalities during autoimmune processes: potential relevance of noradrenaline-induced apoptosis. Ann. N. Y. Acad. Sci. 2003, 992:158-167.
45. Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. USA 1999, 96:1059-1064.
46. Diamantstein T., Ulmer A. The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes. Immunology 1975, 28:113-119.
47. Dobbs C.M., Vasquez M., Glaser R., Sheridan J.F. Mechanisms of stress-induced modulation of viral pathogenesis and immunity. J. Neuroimmunol. 1993, 48:151-160.
48. Edgar V.A., Silberman D.M., Cremaschi G.A., Zieher L.M., Genaro A.M. Altered lymphocyte catecholamine reactivity in mice subjected to chronic mild stress. Biochem. Pharmacol. 2003, 65:15-23.
49. Eijkelkamp N., Cobelens P.M., Sanders V.M., Heijnen C.J., Kavelaars A. Tissue specific effects of the beta 2-adrenergic agonist salbutamol on LPS-induced IFN-gamma, IL-10 and TGF-beta responses in vivo. J. Neuroimmunol. 2004, 150:3-9.
50. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos G.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proceedings of the Association of American Physicians 1996, 108:374-381.
51. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two super-systems: the brain and the immune system. Pharmacol. Rev. 2000, 52:595-638.
52. Feldman R.D., Hunninghake G.W., McArdle W. Betaadrenergic receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J. Immunol. 1987, 139(10):3355-3359.
53. Feldmann M., Brennan F.M., Maini R.N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 1996, 14:397-440.
54. Felten D.L., Felten S.Y., Bellinger D.L., Carlson S.L., Ackerman K.D., Madden K.S., Olschowki J.A., Livnat S. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 1987, 100:225-260.
55. Felten S.Y., Felten D.L. Innervation of lymphoid tissue. Psychoneuroimmunology 1991, 27-69. Academic Press, Inc., New York. 2nd ed. R. Ader, N. Cohen, D. L. Felten (Eds.).
56. Felten S.Y., Madden K.S., Bellinger D.L., Kruszewska B., Moynihan J.A., Felten D.L. The role of the sympathetic nervous system in the modulation of immune responses. Adv. in Pharmacol. 1998, 42:583-587.
57. Ferguson S.S. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol. Rev. 2001, 53:1-24.
58. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
59. Fuchs B.A., Campbell K.S., Munson A.E. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell. Immunol. 1988, 117:339-351.
60. Gajewski T.F., Schell S.R., Fitch F.W. Evidence implicating utilization of different T cell receptor-associated signaling pathways by Th-1 and Th-2 clones. J. Immunol. 1990, 144:4110-4120.
61. Gan X., Zhang L., Solomon G.F., Bonavida B. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotox. Brain Behav. Immun. 2002, 16:227-246.
62. Giorelli M., Livrea P., Trojano M. Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from multiple sclerosis patients. J. Neuroimmunol. 2004, 155:143-149.
63. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 2005, 5:243-251.
64. Glaser R., Kiecolt-Glaser J.K., Marucha P.T., MacCallum R.C., Laskowski B.F., Malarkey W.B. Stress-related changes in proinflammatory cytokine production in wounds. Arch. Gen. Psychiatry 1999, 56:450-456.
65. Gleeson M., Nieman D.C., Pedersen B.K. Exercise, nutrition and immune function. J. Sports Sci. 2004, 22:115-125.
66. Goin J.C., Sterin-Borda L., Borda E.S., Finiasz M., Fernandez J., de Bracco M.M. Active alpha 2 and beta adrenoceptors in lymphocytes from patients with chronic lymphocytic leukemia. Int. J. Cancer 1991, 49:178-181.
67. Goleva E., Dunlap A., Leung D.Y. Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists. J. Allergy Clin. Immunol. 2004, 114:183-191.
68. Hahn P.Y., Yoo P., Ba Z.F., Chaudry I.H., Wang P. Upregulation of Kupffer cell beta-adrenoceptors and cAMP levels during the late stage of sepsis. Biochim. Biophys. Acta. 1998, 1404:377-384.
69. Hall N.R., McClure J.E., Hu S., Tare S., Seals C.M., Goldstein A.L. Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses. Immunopharmacol. 1982, 5:39-48.
70. Harbuz M. Neuroendocrine-immune interactions. Trends Endocrinol. Metab. 2003, 14:51-52.
71. Harle P., Mobius D., Carr D.J., Scholmerich J., Straub R.H. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and of mice with type II collagen-induced arthritis. Arthritis Rheum. 2005, 52:1305-1313.
72. Hatfield S.M., Peterson B.H., DiMicco J.A. Beta-adrenoceptor modulation of the generation of murine cytotoxic T lymphocytes in vitro. J. Pharmacol. Exp. Ther. 1986, 239:460-466.
73. Heijink I.H., Vellenga E., Borger P., Postma D.S., Monchy J.G., Kauffman H.F. Polarized Th1 and Th2 cells are less responsive to negative feedback by receptors coupled to the AC/ cAMP system compared to freshly isolated T cells. Br. J. Pharmacol. 2003, 138:1441-1450.
74. Heijnen C.J., Rouppe van der Voort C., van de Pol M., Kavelaars A. Cytokines regulate alpha (1) -adrenergic receptor mRNA expression in human monocytic cells and endothelial cells. J. Neuroimmunol 2002, 125:66-72.
75. Heijnen C.J., Rouppe van der Voort C., Wulffraat N., van der Net J., Kuis W., Kavelaars A. Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J. Neuroimmunol. 1996, 71:223-226.
76. Hellstrand K., Hermodsson S. An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity. Int. Arch. Allergy Appl. Immunol. 1989, 89:334-341.
77. Hellstrand K., Hermodsson S., Strannegard O. Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells. J. Immunol. 1985, 134:4095-4099.
78. Herrmann M., Scholmerich J., Straub R.H. Stress and rheumatic diseases. Rheum. Dis. Clin. North Am. 2000, 26:737-763. viii.
79. Hetier E., Ayala J., Bousseau A., Prochiantz A. Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse amoeboid microglial cells. Exp. Brain Res. 1991, 86:407-413.
80. Holte H., Torjesen P., Blomhoff H.K., Ruud E., Funderud S., Smeland E.B. Cyclic AMP has the ability to influence multiple events during B cell stimulation. Eur. J. Immunol. 1988, 18:1359-1366.
81. Hudson C.A., Mondal T.K., Cao L., Kasten-Jolly J., Huber V.C., Lawrence D.A. The dietary supplement ephedrine induces beta-adrenergic mediated exacerbation of systemic lupus erythematosus in NZM391 mice. Lupus 2005, 14:293-307.
82. Humbert P.O., Corcoran L.M. Oct-2 gene disruption eliminates the peritoneal B-1 lymphocytes linage and attenuates B-2 cell maturation and function. J. Immunol. 1997, 159:5273-5285.
83. Jetschmann J.U., Benschop R.J., Jacobs R., Kemper A., Oberbeck R., Schmidt R.E., Schedlowski M. Expression and in-vivo modulation of alpha-and beta-adrenoceptors on human natural killer (CD16+) cells. J. Neuroimmunol. 1997, 74:159-164.
84. Johnson D.L., Ashmore R.C., Gordon M.A. Effects of beta-adrenergic agents on the murine lymphocyte response to mitogen stimulation. J. Immunopharmacol. 1981, 3:205-219.
85. Johnson M., Rennard S. Alternative mechanisms for long-acting beta (2) -adrenergic agonists in COPD. Chest 2001, 120:258-270.
86. Kalinichenko V.V., Mokyr M.B., Graf L.H., Jr.Cohen R.L., Chambers D.A. Norepinephrine-mediated inhibition of antitumor cytotoxic T lymphocyte generation involves a beta-adrenergic receptor mechanism and decreased TNF-alpha gene e. J. Immunol. 1999, 163:2492-2499.
87. Kappel M., Poulsen T.D., Galbo H., Pedersen B.K. influence of minor increases in plasma catecholamines on natural killer cell activity. Horm. Res. 1998, 49:22-26.
88. Kasahara K., Tanaka S., Hamashima Y. Suppressed immune response to T-cell dependent antigen in chemically sympathectomized mice. Res. Commun. Chem. Pathol. Pharmacol. 1977, 18:533-542.
89. Kasahara K., Tanaka S., Ito T., Hamashima Y. Suppression of the primary immune response by chemical sympathectomy. Res. Comm. Chem. Pathol. Pharmacol. 1977, 16:687-694.
90. Kasprowicz D.J., Kohm A.P., Berton M.T., Chruscinski A.J., Sharpe A.H., Sanders V.M. Stimulation of the B cell receptor, CD86 (B7-2) , and the beta-2-adrenergic receptor intrinsically modulates the level of IgG1 produced per B cell. J. Immunol. 2000, 165:680-690.
91. Katamura K., Shintaku N., Yamauchi Y., Fukui T., Ohshima Y., Mayumi M., Furusho K. Prostaglandin E2 at priming of naïve CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5. J. Immunol. 1995, 155:4604-4612.
92. Kavelaars A. Regulated expression of alpha-1 adrenergic receptors in the immune system. Brain Behav. Immun. 2002, 16:799-807.
93. Kavelaars A., van de Pol M., Zijlstra J., Heijnen C.J. Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. J. Neuroimmunol. 1997, 77:211-216.
94. Kennedy S.L., Nickerson M., Campisi J., Johnson J.D., Smith T.P., Sharkey C., Fleshner M. Splenic norepinephrine depletion following acute stress suppresses in vivo antibody response. J. Neuroimmunol. 2005, 165:150-160.
95. Khamlichi A.A., Pinaud E., Decourt C., Chauveau C., Cogne M. The 3□CE IgH regulatory region: a complex structure in a search for a function. Adv. Immunol. 2000, 75:317-345.
96. Khan M.M., Melmom K.L., Fathman C.G., Hertel-Wulff B., Strober S. The effects of autocoids on cloned murine lymphoid cells: modulation of IL-2 secretion and the activity of natural suppressor cells. J. Immunol. 1985, 134:4100-4106.
97. Khan M.M., Silverman E., Engleman E.G., Melmon K.L. Responses of subpopulations of human helper T cells to autocoids. Proc. West. Pharmacol. Soc. 1985, 28:225-228.
98. Kiecolt-Glaser J.K., Glaser R. Psychoneuroimmunology and cancer: fact or fiction?. Eur. J. Cancer 1999, 35:1603-1607.
99. Kiecolt-Glaser J.K., Page G.G., Marucha P.T., MacCallum R.C., Glaser R. Psychological influences on surgical recovery. Perspectives from psychoneuroimmunology. Am. Psychol. 1998, 53:1209-1218.
100. Kim U., Qin X.F., Gong S., Stevens S., Luo Y., Nussenzweig M., Roeder R.G. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature 1996, 383:542-547.
101. Kobayashi M., Kobayashi H., Herndon D.N., Pollard R.B., Suzuki F. Burn-associated Candida albicans infection caused by CD30+ type 2 T cells. J. Leukoc. Biol. 1998, 63:723-731.
102. Kohm A.P., Mozaffarian A., Sanders V.M. B cell receptor-and beta-2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J. Immunol. 2002, 168:6314-6322.
103. Kohm A.P., Sanders V.M. Suppression of antigenspecific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J. Immunol. 1999, 162:5299-5308.
104. Kohm A.P., Sanders V.M. Norepinehrine and beta-2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte lymphocyte function in vitro and in vivo. Pharmacol. Rev. 1901, 53:487-525.
105. Kohm A.P., Tang Y., Sanders V.M., Jones S.B. Activation of antigen-specific CD4+ Th2 cells and B cells in vivo increases norepinephrine release in the spleen and bone marrow. J. Immunol. 2000, 165:725-733.
106. Kohut M.L., Thompson J.R., Lee W., Cunnick J.E. Exercise training-induced adaptations of immune response are mediated by beta-adrenergic receptors in aged but not young mice. J. Appl. Physiol. 2004, 96:1312-1322.
107. Kouassi E., Boukhris W., Descotes J., Zukervar P., Li Y.S., Revillard J.P. Selective T cell defects induced by dopamine administration in mice. Immunopharmacol. Immunotoxicol. 1987, 9:477-488.
108. Krause D.S., Deutsch C. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: expression of both p55and 75subunits is affected. J. Immunol. 1991, 146:2285-2294..
109. Kruszewska B., Felten S.Y., Moynihan J.A. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice. J. Immunol. 1995, 155:4613-4620.
110. Lacour M., Arrighi J., Muller K.M., Carlberg C., Saurat J., Hauser C. cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. Int. Immunol. 1994, 6:1333-1343.
111. 2-adrenergic mechanisms in experimental arthritis. Proc. Natl. Acad. Sci. USA 1988, 85:4553-4556.
112. Li Y.S., Kouassi E., Revillard J.-P. Cyclic AMP can enhance mouse B cell activation by regulating progression into late G1/S phase. Eur. J. Immunol. 1989, 19:1721-1725.
113. Livnat S., Felten S.Y., Carlson S.L., Bellinger D.L., Felten D.L. Involvement of peripheral and central catecholamine systems in neural-immune interactions. J. Neuroimmunol. 1985, 10:5-30.
114. Lombardi M.S., Kavelaars A., Cobelens P.M., Schmidt R.E., Schedlowski M., Heijnen C.J. Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J. Immunol. 2001, 166:1635-1640.
115. Lombardi M.S., Kavelaars A., Heijnen C.J. Role and modulation of G protein-coupled receptor signaling in inflammatory processes. Crit. Rev. Immunol. 2002, 22:141-163.
116. Lombardi M.S., Kavelaars A., Schedlowski M., Bijlsma J.W., Okihara K.L., van de Pol M., Ochsmann S., Pawlak C., Schmidt R.E., Heijnen C.J. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J. 1999, 13:715-725.
117. Loop T., Bross T., Humar M., Hoetzel A., Schmidt R., Pahl H.L., Geiger K.K., Pannen B.H. Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factorkappaB in human T lymphocytes in vitro. Anesth. Analg. 2004, 99:1508-1515. table of contents.
118. Madden K.S., Felten S.Y., Felten D.L., Sundaresan P.R., Livnat S. Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and in vitro following chemical sympathectomy. Brain Behav. Immun. 1989, 3:72-89.
119. Madden K.S., Stevens S.Y., Felten D.L., Bellinger D.L. Alterations in T lymphocyte activity following chemical sympathectomy in young and old Fischer 344 rats. J. Neuroimmunol. 2000, 103:131-145.
120. Maestroni G.J. Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J. Immunol. 2000, 165:6743-6747.
121. Maestroni G.J. Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development. J. Neuroimmunol. 2002, 129:106-114.
122. Maestroni G.J., Mazzola P. Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. J. Neuroimmunol. 2003, 144:91-99.
123. Maisel A.S., Michel M.C. Beta-adrenoceptor control of immune function in congestive heart failure. Br. J. Clin. Pharmacol. 1990, 30:49S-53S. Suppl 1.
124. Manfield L.E., Nelson H.S. Effect of beta-adrenergic agents on immunoglobulin G levels in asthmatic subjects. Int. Arch. Allergy Appl. Immunol. 1982, 68:13-16.
125. Mary D., Peyron J.-F., Auberger P., Aussel C., Fehlmann M. Modulation of T cell activation by differential regulation of the phosphorylation of two cytosolic proteins. J. Biol. Chem. 1989, 264:14498-14502.
126. Mathews P.M., Froelich C.J., Sibbitt W.L., Bankhurst A.D. Enhancement of natural cytotoxicity by â-endorphin. J. Immunol. 1983, 130:1658-1662.
127. Matthews K.A., Caggiula A.R., McAllister C.G., Berga S.L., Owens J.F., Flory J.D., Miller A.L. Sympathetic reactivity to acute stress and immune response in women. Psychosom. Med. 1995, 57:564-571.
128. McPherson G.A., Summers R.J. Characteristics and localization of 3H-clonidine binding in membranes prepared from guinea pig spleen. Clin. Exp. Pharmacol. Physiol. 1982, 9:77-87.
129. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., Ben Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antago and a prostaglandin synthesis inhibitor. Brain Behav. Immun. 2005, 19:114-126.
130. Meltzer J.C., Grimm P.C., Greenberg A.H., Nance D.M. Enhanced immunohistochemical detection of autonomic nerve fibers, cytokines and inducible nitric oxide synthase by light and fluorescent microscopy in rat s. J. Histochem. Cytochem. 1997, 45:599-610.
131. Miles B.A., Lafuse W.P., Zwilling B.S. Binding of alpha-adrenergic receptors stimulates the anti-mycobacterial activity of murine peritoneal macrophages. J. Neuroimmunol. 1996, 71:19-24.
132. Miles K., Quintans J., Chelmicka-Schorr E., Arnason B.G.W. The sympathetic nervous system modulates antibody response to thymus-independent antigens. J. Neuroimmunol. 1981, 1:101-105.
133. Mills P.J., Rehman J., Ziegler M.G., Carter S.M., Dimsdale J.E., Maisel A.S. Nonselective beta blockade attenuates the recruitment of CD62L (-) T lymphocytes following exercise. Eur. J. Appl. Physiol. 1999, 79:531-534.
134. Mitchell D.M., Fries J.F. An analysis of the American Rheumatism Association criteria for rheumatoid arthritis. Arthritis Rheum. 1982, 25:481-487.
135. Munoz E., Zubiaga A.M., Merrow M., Sauter N.P., Huber B.T. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 1990, 172:95-103.
136. Muraguchi A., Miyazaki K., Kehrl J.H., Fauci A.S. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle. J. Immunol. 1984, 133:1283-1287.
137. Muthusamy N., Baluyut A.R., Subbarao B. Differential regulation of surface Ig-and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two diffe receptors linked to phosphatidylinositol hydrolysis in murine B cells. J. Immunol. 1991, 147:2483-2492.
138. Naito Y., Endo H., Arai K., Coffman R.L., Arai N. Signal transduction in Th clones: target of differential modulation by PGE2 may reside downstream of the PKC-dependent pathway. Cytokine 1996, 8:346-356.
139. Nielsen P.J., Georgiev O., Lorenz B., Schaffner W. B lymphocytes are impaired in mice lacking the transcrip-tional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol. 1996, 26:3214-3218.
140. Novak T.J., Rothenberg E.V. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Natl. Acad. Sci. USA 1990, 87:9353-9357.
141. O'Dowd Y.M., El-Benna J., Perianin A., Newsholme P. Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst in human neutrophils by adrenaline: inhibition of phospholipase A2 activity b p47phox phosphorylation and translocation. Biochem. Pharmacol. 2004, 67:183-190..
142. Paliogianni F., Boumpas D.T. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-. Cell. Immunology 1996, 171:95-101.
143. Panina-Bordignon P., Mazzeo D., Lucia P.D., D'Ambrosio D., Lang R., Fabbri L., Self C., Sinigaglia F. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J. Clin. Invest. 1997, 100:1513-1519.
144. Panosian J.O., Marinetti G.V. Alpha 2-adrenergic receptors in human polymorphonuclear leukocyte membranes. Biochem. Pharmacol. 1983, 32:2243-2247.
145. Panuncio A.L., De La Pena S., Gualco G., Reissenweber N. Adrenergic innervation in reactive human lymph nodes. J. Anat. 1998, 194:143-146.
146. Park S.H., Min D.J., Cho M.L., Kim W.U., Youn J., Park W., Cho C.S., Kim H.Y. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis Rheum. 2001, 44:561-569.
147. Parker C.W., Huber M.G., Godt S.M. Modulation of IL-4 production in murine spleen cells by prostaglandins. Cell. Immunol. 1995, 160:278-285.
148. Pinaud E., Khamlichi A.A., Le Morvan C., Drouet M., Nelsso V., Le Bert M., Cogne M. Localization of the 3□CE IgH locus elements that effect long-distance regulation of class switching recombination. Immunity 2001, 15:187-199.
149. Pochet R., Delespesse G. Beta-adrenoceptors display different efficiency on lymphocyte subpopulations. Biochem. Pharmacol. 1983, 32:1651-1655.
150. Podojil J., Sanders V. CD86 and beta2-adrenergic receptor stimulation regulate B cell activity cooperatively. Trends in Immunology 2005, 26:180-185.
151. Podojil J.R., Kin N.W., Sanders V.M. CD86 and beta2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B expression and binding to the 3□CE-IgH enhancer in B cells. J. Biol. Chem. 2004, 279:23394-23404.
152. Podojil J.R., Sanders V.M. Selective regulation of mature IgG1 transcription by CD86 and beta2-adrenergic receptor stimulation. J. Immunol. 2003, 170:5143-5151.
153. Prass K., Meisel C., Hoflich C., Braun J., Halle E., Wolf T., Ruscher K., Victorov I.V., Priller J., Dirnagl U., Volk H.D., Meisel A. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 2003, 198:725-736.
154. Radojcic T., Baird S., Darko D., Smith D., Bulloch K. Changes in beta-adrenergic receptor distribution on immuno-cytes during differentiation: an analysis of T cells and macrophages. J. Neurosci. Res. 1991, 30:328-335.
155. Ramer-Quinn D.S., Baker R.A., Sanders V.M. Activated Th1 and Th2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of Th1 cell cytokine production. J. Immunol. 1997, 159:4857-4867.
156. Ramer-Quinn D.S., Swanson M.A., Lee W.T., Sanders V.M. Cytokine production by naïve and primary effector CD4 (+) T cells exposed to norepinephrine. Brain Behav. Immun. 2000, 14:239-255.
157. Rice P.A., Boehm G.W., Moynihan J.A., Bellinger D.L., Stevens S.Y. Chemical sympathectomy increases the innate immune response and decreases the specific immune response in the spleen to infection with Listeria monocytogenes. J. Neuroimmunol. 2001, 114:19-27.
158. Roberts J.A., Bradding P., Britten K.M., Walls A.F., Wilson S., Gratziou C., Holgate S.T., Howarth P.H. The longacting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma [see comments]. Eur. Respir. J. 1999, 14:275-282.
159. Robinson F.P., Mathews H.L., Witek-Janusek L. Stress reduction and HIV disease: a review of intervention studies using a psychoneuroimmunology framework. J. Assoc. Nurses 2000, 11:87-96.
160. Romagnani S. Lymphokine production by human T cells in disease states. Ann. Rev. Immunol. 1994, 12:227-257.
161. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 1700, 85:9-18. quiz18, 21.
162. Roper R.L., Conrad D.H., Brown D.M., Warner G.L., Phipps R.P. Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis. J. Immunol. 1990, 145:2644-2651.
163. Roper R.L., Graf B., Phipps R.P. Prostaglandin E2 and cAMP promote B lymphocyte class switching to IgG1. Immunol. Lett. 2002, 84:191-198.
164. Rouppe van der Voort C., Heijnen C.J., Wulffraat N., Kuis W., Kavelaars A. Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role fo alpha (1) -adrenergic receptors. J. Neuroimmunol. 2000, 110:223-229.
165. Rouppe van der Voort C., Kavelaars A., van de Pol M., Heijnen C.J. Neuroendocrine mediators up-regulate alpha1b-and alpha1d-adrenergic receptor subtypes in human monocytes. J. Neuroimmunol. 1999, 95:165-173.
166. Rouppe van der Voort C., Kavelaars A., van de Pol M., Heijnen C.J. Noradrenaline induces phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of alpha (1) -adrenergic receptors. J. Neuroimmunol. 2000, 108:82-91.
167. Rozlog L.A., Kiecolt-Glaser J.K., Marucha P.T., Sheridan J.F., Glaser R. Stress and immunity: implications for viral disease and wound healing. J. Periodontol. 1999, 70:786-792.
168. Sanders V.M., Baker R.A., Ramer-Quinn D.S., Kasprowicz D.J., Fuchs B.A., Street N.E. Differential expression of the beta-2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J. Immunol. 1997, 158:4200-4210.
169. Sanders V.M., Kasprowicz D.J., Kohm A.P., Swanson M.A. Neurotransmitter receptors on lymphocytes and other lymphoid cells. Psychoneuroimmunology 2001, vol. 2:161-196. Academic Press., San DiegoCA. 3rd ed. R. Ader, N. Cohen (Eds.).
170. Sanders V.M., Munson A.E. Beta-adrenoceptor mediation of the enhancing effect of norepinephrine on the mu-rine primary antibody response in vitro. J. Pharmacol. Exp. Ther. 1984, 230(1):183-192.
171. Sanders V.M., Munson A.E. Kinetics of the enhancing effect produced by norepinephrine and terbutaline on the mu-rine primary antibody response in vitro. J. Pharmacol. Exp. Ther. 1984, 231(3):527-531.
172. Sanders V.M., Munson A.E. Norepinephrine and the antibody response. Pharmacol. Rev. 1985, 37(3):229-248.
173. Sanders V.M., Munson A.E. Role of alpha adrenoceptor activation in modulating the murine primary antibody response in vitro. J. Pharmacol. Exp. Ther. 1985, 232(2):395-400.
174. Schedlowski M., Falk A., Rohne A., Wagner T.O., Jacobs R., Tewes U., Schmidt R.E. Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells. J. Clin. Immunol. 1993, 13:344-351.
175. Schorr E.C., Arnason B.G. Interactions between the sympathetic nervous system and the immune system. Brain Behav. Immun. 1999, 13:271-278.
176. Schubart D.B., Rolink A., Kosco-Vilbois M.H., Botteri F., Matthias P. B-cell-specific coactivator OBF-1/OCA-B/ Bob1 required for immune response and germinal centre formation. Nature 1996, 383:538-542.
177. Seiffert K., Hosoi J., Torii H., Ozawa H., Ding W., Campton K., Wagner J.A., Granstein R.D. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J. Immunol. 2002, 168:6128-6135.
178. Sheridan J.F., Dobbs C., Jung J., Chu X., Konstantinos A., Padgett D., Glaser R. Stress-induced neuroendocrine modulation of viral pathogenesis and immunity. Ann. N. Y. Acad. Sci. 1998, 840:803-808.
179. Shimizu N., Hori T., Nakane H. An interleukin-1-betainduced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: an in vivo microdialysis study in consci. Brain Behav. Immun. 1994, 7:14-23.
180. Silberman D.M., Wald M.R., Genaro A.M. Acute and chronic stress exert opposing effects on antibody responses associated with changes in stress hormone regulation of Tlymphocyte reactivity. J. Neuroimmunol. 2003, 144:53-60.
181. Sondergaard S.R., Cozzi Lepri A., Ullum H., Wiis J., Hermann C.K., Laursen S.B., Qvist J., Gerstoft J., Skinhoj P., Pedersen B.K. Adrenaline-induced mobilization of T cells in HIV-infected patients. Clin. Exp. Immunol. 2000, 119:115-122.
182. Speidl W.S., Toller W.G., Kaun C., Weiss T.W., Pfaffenberger S., Kastl S.P., Furnkranz A., Maurer G., Huber K., Metzler H., Wojta J. Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for perioperative plaque instability. FASEB J. 2004, 18:603-605.
183. Spengler R.N., Allen R.M., Remick D.G., Strieter R.M., Kunkel S.L. Stimulation of alpha-adrenergic receptor augments the production of macrophage-derived tumor necrosis factor. J. Immunol. 1990, 145:1430-1434.
184. Stavnezer-Nordgren J., Sirlin S. Specificity of immunoglobulin heavy chain switch correlates with activity of germline heavy chain genes prior to switching. EMBO J. 1986, 5:95-102.
185. Stein S.H., Phipps R.P. Antigen-specific IgG2a production in response to prostaglandin E2, immune complexes, and IFN-gamma. J. Immunol. 1991, 147:2500-2506.
186. Stein S.H., Phipps R.P. Elevated levels of intracellular cAMP sensitize resting B lymphocytes to immune complexinduced unresponsiveness. Eur. J. Immunol. 1991, 21:313-318.
187. Stein S.H., Phipps R.P. Anti-class II antibodies potentiate IgG2a production by lipopolysaccharide-stimulated B lymphocytes treated with prostaglandin E2 and IFN-gamma. J. Immunol. 1992, 148:3943-3949.
188. Steinman L. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 2004, 5:575-581.
189. Stevens S., Ong J., Kim U., Eckhardt L.A., Roeder R.G. Role of OCA-B in 3□CE-IgH enhancer function. J. Immunol. 2000, 164:5306-5312.
190. Straub R.H. Complexity of the bi-directional neuroimmune junction in the spleen. Trends Pharmacol. Sci. 2004, 25:640-646.
191. Straub R.H., Baerwald C.G., Wahle M., Janig W. Autonomic dysfunction in rheumatic diseases. Rheum. Dis. Clin. North Am. 2005, 31:61-75. viii.
192. Straub R.H., Harle P. Sympathetic neurotransmitters in joint inflammation. Rheum. Dis. Clin. North Am. 2005, 31:43-59. viii.
193. Straub R.H., Pongratz G., Weidler C., Linde H.J., Kirschning C.J., Gluck T., Scholmerich J., Falk W. Ablation of the sympathetic nervous system decreases gram-negative and increases gram-positive bacterial dissemination: key roles for tumor necrosis factor/ph and interleukin-4/lymphocytes. J. Infect. Dis. 2005, 192:560-572.
194. Strom T.B., Carpenter C.B., Garovoy M.R., Austen K.F., Merrill J.P., Kaliner M. The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity. J. Exp. Med. 1973, 138:381-393.
195. Swanson M.A., Lee W.T., Sanders V.M. IFN-gamma production by Th1 cells generated from naïve CD4 (+) T cells exposed to norepinephrine. J. Immunol. 2001, 166:232-240.
196. Takahashi H., Kobayashi M., Tsuda Y., Herndon D.N., Suzuki F. Contribution of the sympathetic nervous system on the burn-associated impairment of CCL3 production. Cytokine 2005, 29:208-214.
197. Takahashi H., Tsuda Y., Kobayashi M., Herndon D.N., Suzuki F. Increased norepinephrine production associated with burn injuries results in CCL2 production and type 2 T cell generation. Burns 2004, 30:317-321.
198. Takamoto T., Hori Y., Koga Y., Toshima H., Hara A., Yokoyama M.M. Norepinephrine inhibits human natural killer cell activity in vitro. Int. J. Neurosci. 1991, 58:127-131.
199. Takayama H., Trenn G., Sitkovsky M.V. Locus of inhibitory action of cAMP-dependent protein kinase in the antigen receptor-triggered cytotoxic T lymphocyte activation pathway. J. Biol. Chem. 1988, 263:2330-2336.
200. Tamir A., Isakov N. Cyclic AMP inhibits phosphatidylinositol-coupled and-uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulat members of the jun and fos family of genes. J. Immunol. 1994, 152:3391-3399.
201. Tang H., Sharp P.A. Transcriptional regulation of the murine 3□CE IgH enhancer by OCT-2. Immunity 1999, 11:517-526.
202. Thompson M., Bywaters E.G. Unilateral rheumatoid arthritis following hemiplegia. Ann. Rheum. Dis. 1962, 21:370-377.
203. ThyagaRajan S., Madden K.S., Stevens S.Y., Felten D.L. Effects of L-deprenyl treatment on noradrenergic innervation and immune reactivity in lymphoid organs of young F344 rats. J. Neuroimmunol. 1999, 96:57-65.
204. Titinchi S., Clark B. Alpha-2-adrenoceptors in human lymphocytes: direct characterization by [3H]Yohimbine binding. Biochem. Biophys. Res. Commun. 1984, 121(1):1-7.
205. Tonnesen E., Christensen N.J., Brinklov M.M. Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers. Eur. J. Clin. Invest. 1987, 17:497-503.
206. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
207. van der Poll T., Jansen J., Endert E., Sauerwein H.P., van Deventer S.J. Noradrenaline inhibits lipopolysaccharideinduced tumor necrosis factor and interleukin 6 production in human whole blood. Infect. Immun. 1994, 62:2046-2050.
208. van der Poll T., Lowry S.F. Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am. J. Physiol. 1997, 273:R1885-R1890.
209. van der Poll T., Lowry S.F. Lipopolysaccharideinduced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. Infect. Immun. 1997, 65:2378-2381.
210. Vischer T.L. The differential effect of cAMP on lymphocyte stimulation by T-or B-cell mitogens. Immunology 1976, 30:735-739.
211. Vroon A., Kavelaars A., Limmroth V., Lombardi M.S., Goebel M.U., Van Dam A.M., Caron M.G., Schedlowski M., Heijnen C.J. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J. Immunol. 2005, 174:4400-4406.
212. Wacholtz M.C., Minakuchi R., Lipsky P.E. Characterization of the 3□CE,5□CE-cyclic adenosine monophosphate-mediated regulation of IL2 production by T cells and Jurkat cells. Cell. Immunol. 1991, 135:285-298.
213. Watson J. The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis. J. Exp. Med. 1975, 141:97-111.
214. Watkins L.R., Maier S.F. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J. Intern. Med. 2005, 257:139-155.
215. Westly H.J., Kelley K.W. Down-regulation of glucocorticoid and beta-adrenergic receptors on lectin-stimulated splenocytes. Proc. Soc. Exp. Biol. Med. 1987, 185:211-218.
216. Whisler R.L., Beiqing L., Grants I.S., Newhouse Y.G. Cyclic AMP modulation of human B cell proliferative responses: role of cAMP-dependent protein kinases in enhancing B cell responses to phorbol diesters and io. Cell. Immunol. 1992, 142:398-415.
217. Wirth S., Lacour M., Jaunin F., Hauser C. Cyclic adenosine monophosphate (cAMP) differentially regulates IL-4 in thymocyte subsets. Thymus 1996, 24:101-109.
218. Xu B.Y., Arlehag L., Rantapaa-Dahlquist S.B., Lefvert A.K. Beta2 adrenoceptor gene single nucleotide polymorphisms are associated with rheumatoid arthritis in northern Sweden. Ann. Rheum. Dis. 2005, 64:773-776.
219. Yin Z., Siegert S., Neure L., Grolms M., Liu L., Eggens U., Radbruch A., Braun J., Sieper J. The elevated ratio of interferon gamma-/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be interleukin-4 but not by interleukin-10 or transforming growth factor beta. Rheumatology (Oxford) 1999, 38:1058-1067.
220. Yoshimura T., Nagao T., Nakao T., Watanabe S., Usami E., Kobayashi J., Yamazaki F., Tanaka H., Inagaki N., Nagai H. Modulation of Th1-and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclear cells by phosphodiesterase inhibitors. Gen. Pharmacol. 1998, 30:175-180.